Cellectis S.A.

CLLS chart

Cellectis S.A. news

• Cellectis Reports 90% Gene Editing in Preclinical Study

  grafa.com · Oct 27, 7:41 AM EDT

• Cellectis S.A. (CLLS) Stock Price, News, Quote & History

  Yahoo! Finance Canada · Oct 27, 5:51 AM EDT

• Cellectis Presents Preclinical Data Highlighting Efficient APOC3 Editing and Marked Triglyceride Reduction with .HEAL-101 at ESGCT 2026

  Yahoo Finance · Oct 27, 3:15 AM EDT

• One dose lowered blood fats by 75% on average in mice. Cellectis plans a China trial.

  Stock Titan · Oct 27, 3:15 AM EDT

• European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading

  Yahoo Finance · Oct 26, 11:12 AM EDT

• Cellectis S.A. (NASDAQ:CLLS) Stock Has Consensus Target Price of $5.46 According to Analysts

  MarketBeat · Oct 25, 7:03 AM EDT

• Cellectis S.A. Estimates – EURONEXT:ALCLS

  TradingView · Oct 23, 12:12 PM EDT

• INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cellectis S.A. - CLLS

  PR Newswire · Oct 22, 10:00 AM EDT

• Multiple Myeloma Pipeline 2026: Who Is Leading the Race? Top

  openPR.com · Oct 20, 9:44 PM EDT

• European Equities Traded in the US as American Depositary Receipts Rise Sharply in Thursday Trading

  Yahoo Finance · Oct 15, 11:19 AM EDT

• European Equities Traded in the US as American Depositary Receipts Edge Lower in Wednesday Trading

  Yahoo Finance · Oct 14, 11:10 AM EDT

• European Equities Traded in the US as American Depositary Receipts Open Higher in Monday Trading

  Yahoo Finance · Oct 12, 11:14 AM EDT

Cellectis S.A. key financials

No XBRL financial data is available for this company yet.

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 6-KFORM 6-K2026-09-14
• 6-KFORM 6-K2026-09-11
• 6-KFORM 6-K2026-09-01
• 6-KFORM 6-K2026-08-06
• 6-K6-K2026-08-06
• 6-KFORM 6-K2026-07-30
• 6-KFORM 6-K2026-06-25
• 6-K6-K2026-06-25
• 6-KFORM 6-K2026-06-11
• 6-KFORM 6-K2026-06-09
• 6-K6-K2026-05-21
• 6-KFORM 6-K2026-05-20

About Cellectis S.A.

Ticker

CLLS (Nasdaq)

Industry

Biological Products, (No Diagnostic Substances)

Headquarters

Paris, Lle-De-France

Incorporated in

France

Fiscal year end

December 31

SEC CIK

1627281

Frequently asked questions